Imaz A - Search Results

1

Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients.

Curran A, Gutirerrez M, Deig E, Mateo G, Lopez RM, Imaz A, Crespo M, Ocaña I, Domingo P, Ribera E. Curran A, et al. Among authors: imaz a. J Antimicrob Chemother. 2010 Oct;65(10):2195-203. doi: 10.1093/jac/dkq295. Epub 2010 Aug 16. J Antimicrob Chemother. 2010. PMID: 20713406

2

Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome.

Curran A, Falcó V, Crespo M, Martinez X, Ribera E, Villar del Saz S, Imaz A, Coma E, Ferrer A, Pahissa A. Curran A, et al. Among authors: imaz a. HIV Med. 2008 Oct;9(8):609-15. doi: 10.1111/j.1468-1293.2008.00603.x. Epub 2008 Jun 28. HIV Med. 2008. PMID: 18557951 Free article.

3

Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.

Van den Eynde E, Crespo M, Esteban JI, Jardi R, Ribera E, Carbonell J, Rodríguez-Frias F, Falco V, Curran A, Imaz A, Villar del Saz S, Ocaña I, Esteban R, Pahissa A. Van den Eynde E, et al. Among authors: imaz a. Clin Infect Dis. 2009 Apr 15;48(8):1152-9. doi: 10.1086/597470. Clin Infect Dis. 2009. PMID: 19275492 Clinical Trial.

4

Impact of prior pneumococcal vaccination on clinical outcomes in HIV-infected adult patients hospitalized with invasive pneumococcal disease.

Imaz A, Falcó V, Peñaranda M, Jordano Q, Martínez X, Nadal C, Curran A, Planes AM, Dalmau D, Ribera E, Riera M, Ruiz de Gopegui E, Pahissa A. Imaz A, et al. HIV Med. 2009 Jul;10(6):356-63. doi: 10.1111/j.1468-1293.2009.00695.x. Epub 2009 Mar 11. HIV Med. 2009. PMID: 19490180 Free article.

5

Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infection.

Imaz A, del Saz SV, Ribas MA, Curran A, Caballero E, Falcó V, Crespo M, Ocaña I, Diaz M, de Gopegui ER, Riera M, Ribera E. Imaz A, et al. J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):382-6. doi: 10.1097/QAI.0b013e3181b17f53. J Acquir Immune Defic Syndr. 2009. PMID: 19654552

6

Efficacy and safety of switching from enfuvirtide to raltegravir in patients with virological suppression.

Santos JR, Llibre JM, Ferrer E, Domingo P, Imaz A, Moltó J, Martin-Iguacel R, Caum C, Podzamczer D, Clotet B. Santos JR, et al. Among authors: imaz a. HIV Clin Trials. 2009 Nov-Dec;10(6):432-8. doi: 10.1310/hct1006-432. HIV Clin Trials. 2009. PMID: 20133273

7

Short communication: high effectiveness of etravirine in routine clinical practice in treatment-experienced HIV type 1-infected patients.

Santos JR, Llibre JM, Domingo P, Imaz A, Ferrer E, Podzamczer D, Bravo I, Ribera E, Videla S, Clotet B. Santos JR, et al. Among authors: imaz a. AIDS Res Hum Retroviruses. 2011 Jul;27(7):713-7. doi: 10.1089/AID.2010.0283. Epub 2011 Jan 15. AIDS Res Hum Retroviruses. 2011. PMID: 21114458 Free article.

8

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.

Imaz A, Llibre JM, Mora M, Mateo G, Camacho A, Blanco JR, Curran A, Santos JR, Caballero E, Bravo I, Gayá F, Domingo P, Rivero A, Falcó V, Clotet B, Ribera E. Imaz A, et al. J Antimicrob Chemother. 2011 Feb;66(2):358-62. doi: 10.1093/jac/dkq432. Epub 2010 Dec 14. J Antimicrob Chemother. 2011. PMID: 21172789

9

Antiretroviral salvage therapy for multiclass drug-resistant HIV-1-infected patients: from clinical trials to daily clinical practice.

Imaz A, Falcó V, Ribera E. Imaz A, et al. AIDS Rev. 2011 Jul-Sep;13(3):180-93. AIDS Rev. 2011. PMID: 21799536 Review.

10

The role of inactive nucleoside/nucleotide reverse transcriptase inhibitors in salvage therapy for drug-resistant HIV-1 infection in the era of new classes and new generation antiretrovirals.

Imaz A, Llibre JM, Ribera E, Clotet B, Podzamczer D. Imaz A, et al. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e46-8. doi: 10.1097/QAI.0b013e31822c5da1. J Acquir Immune Defic Syndr. 2011. PMID: 21921728 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters